Ibrutinib resistance-mechanisms and options in CLL

Поделиться
HTML-код
  • Опубликовано: 27 июл 2024
  • In this presentation from Lymphoma & Myeloma 2016, Dr. Y. Lynn Wang discusses ibrutinib resistance-mechanisms in the treatment of chronic lymphocytic leukemia (CLL).
    Earn CME credit for a related activity at the following location:
    elc.imedex.com/ELC/Specialty-S...
    © 2016 Imedex, LLC.

Комментарии • 2